Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
9 studies found for:    "Factor XIII deficiency"
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency
Condition: Factor XIII Deficiency
Intervention: Biological: FXIII Concentrate (Human)
2 Completed
Has Results
An Open Enrollment Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency
Condition: Factor XIII Deficiency
Intervention: Biological: FXIII Concentrate (Human) (FXIII)
3 Completed
Has Results
A Study of the Use of Factor XIII Concentrate in Patients With Inherited FXIII Deficiency
Condition: Factor XIII Deficiency
Intervention: Biological: FXIII Concentrate (Human)
4 Completed Clinical Trial of Factor XIII (FXIII) Concentrate
Conditions: Hemophilia;   Factor XIII Deficiency
Intervention: Drug: Fibrogammin P
5 Recruiting Wound Healing Abnormalities in Major Abdominal Surgery
Conditions: Impaired Wound Healing;   Factor XIII Deficiency
Intervention:
6 Completed Safety of Monthly Recombinant Factor XIII Replacement Therapy in Subjects With Congenital Factor XIII Deficiency: An Extension to Trial F13CD-1725
Conditions: Congenital Bleeding Disorder;   Congenital FXIII Deficiency
Intervention: Drug: catridecacog
7 Unknown  Factor XIII and Pulmonary Embolism in Neurosurgical Patients
Conditions: Brain Tumor;   Vascular Lesion;   Factor XIII Deficiency;   Pulmonary Embolism
Intervention:
8 Completed Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll Deficiency
Conditions: Congenital Bleeding Disorder;   Congenital FXIII Deficiency
Intervention: Drug: catridecacog
9 Completed
Has Results
Evaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients With FXIII Inherited Deficiency
Conditions: Congenital Bleeding Disorder;   Congenital FXIII Deficiency
Intervention: Drug: catridecacog

Study has passed its completion date and status has not been verified in more than two years.